Comparative Dose-Related Time-Action Profiles of Glibenclamide and a New Non-Sulphonylurea Drug, AG-EE 623 ZW, During Euglycaemic Clamp in Healthy Subjects

Diabetologia - Germany
doi 10.1007/bf00417695
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Comparative Dose-Related Time-Action Profiles of Glibenclamide and a New Non-Sulphonylurea Drug, AG-EE 623 ZW, During Euglycaemic Clamp in Healthy Subjects

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1994English

Dose-Response Study With High-Dose Inhaled Salmeterol in Healthy Subjects.

British Journal of Clinical Pharmacology
Pharmacology
1992English

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects

Clinical Drug Investigation
MedicinePharmacology
2017English

The Dose Response of Inhaled LPS Challenge in Healthy Subjects

European Journal of Inflammation
2018English

Metformin and Glibenclamide: Comparative Risks.

BMJ
1984English

Age Related Changes of the Walking Cycle During Fastest Walking in Healthy Male Subjects.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1989English

The Effect of Hyperinsulinaemic-Euglycaemic Clamp and Exercise on Bone Remodeling Markers in Obese Men

BoneKEy Reports
2015English

Pharmacokinetics of the Antimalarial Drug Piperaquine in Healthy Vietnamese Subjects

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2008English

Pulmonary Hemodynamics During a Strenuous Intermittent Exercise in Healthy Subjects

Medicine and Science in Sports and Exercise
Sports MedicinePhysical TherapySports ScienceOrthopedicsSports TherapyRehabilitation
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy